• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of protein kinase C and chimaerin in esophageal cancer cells

Research Project

Project/Area Number 13671361
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionKurume University

Principal Investigator

FUJII Teruhiko  KURUME UNIVERSITY, SCHOOL OF MEDICINE, ASSISTANT PROFESSOR, 医学部, 講師 (50199288)

Co-Investigator(Kenkyū-buntansha) YAMANA Hideaki  KURUME UNIVERSITY, SCHOOL OF MEDICINE, PROFESSOR, 医学部, 教授 (30140669)
SUEYOSHI Susumu  KURUME UNIVERSITY, SCHOOL OF MEDICINE, ASSISTANT PROFESSOR, 医学部, 講師 (30235840)
主藤 朝也  久留米大学, 医学部, 助手 (50309803)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2003: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2002: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2001: ¥1,100,000 (Direct Cost: ¥1,100,000)
Keywordsesophageal cancer / protein kinase C / b2 chimaerin / protein kinase C(PKC) / β2chimaerin
Research Abstract

PKC and β2chimaerin play important role in intracellular signaling, however, the role of PKC and β2chimaerin are not clear in esophageal cancer cells. The aim of this study was to explore the role of PKCδ and β2chimaerin as a mediator of phorbor ester-mediated responses in KE3 esophageal cancer cells. The phorbor ester PMA induces G_2 cell cycle arrest in KE3 esophageal cancer cells. A significant inhibition in cell number was observed upon infection with PKCδAdV, however, β2chimaerin overexpression did not cause any significant changes in cell number or cell cycle ditribution. PKCδ is closely involved in PMA-induced inhibition in KE3 cell growth. The results. of the experiments with ChimAdV exclude the possibility of β2chimaerin involvement. However, β2chimaerin plays important role in intracellular signaling, further study is required.

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Garcia-Bermejo ML et al.: "DAG-lactones, a new class of PKC agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKC α"J Biol Chem. 277. 645-655 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujii T. et al.: "Climicopathologic study of revascularization and VEGF expression in superficial esophageal carcinoma"Int J Oncol. 21. 1181-1187 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakagawa S. et al.: "Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells"Mol Carcinogen. 38. 106-116 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujii T. et al.: "Immunohistological study of cell cycle-related factor, oncogene expression, cell proliferation in adenocarchom a of Barrett's esophagus"Oncol Rep. 10. 427-431 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tanaka Y, et al.: "Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway"J Biol Chem. 278. 33753-33762 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Garcia-Bermejo ML, Leskow FC, Fujii T, Wang Q, Blumberg P, Ohba M, Kuroki T, Lee J, Marquez V, Kazanietz MG.: "DAG-lactones, a new class of PKC agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCα"J Biol Chem. 277. 645-655 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujii_T, Sudo T, Sueyoshi S, Tanaka T, Fujita H, Shirouzu K, Ban S, Toyonaga A, Kato S, Yamana H.: "Clinicopathologic study of noevascularization and VEGF expression in superficial esophageal carcinoma."Int J Oncol. 21. 1181-1187 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakagawa S, Fujii_T, Yokoyama G, Kazanietz MG, Yamana H, Shirouzu K.: "Cell Growth Inhibition by All-trans Retinoic Acid in SKBR-3 Breast Cancer Cells : Involvement of protein kinase C α and extracellular signal-regulated kinase mitogen-activated protein kinase."Mol Carcinogen. 38. 106-116 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujii T, Nakagawa S, Hanzawa M, Sueyoshi S, Fujita H, Shirouzu K, Yamana H.: "Immunohistological Study of Cell Cycle-Related Factors, Oncogene Expression, Cell proliferation in adenocarcinoma of Barrett's Esophagus."Oncol Rep. 10. 427-431 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tanaka Y, M.Gavrielides V, Mitsuuchi Y, Fujii T, Kazanietz MG: "Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through the activation of p38 MAPK and inhibition of the Akt survival pathway."J Biol Chem. 278. 33753-33762 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Azuma K, Shichijo 5, Maeda Y, Nonaka Y, Fujii T, Koike K, Itoh K.: "Mutated p53 gene encodes a non-mutated epitope recognized by HLA-B4601-restricted and tumor-reactive CTLs at tumor site."Cancer Res. 15. 854-858 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tanaka Y, Gavrielides V, Mitsuuchi Y, Fujii T et al.: "Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through the activation of p38 MAPK and inhibition of the Akt survival pathway."J Biol Chem. 278. 33753-33762 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Azuma K, Shichijo S, Maeda Y, Nonaka Y, Fujii T et al.: "Mutated p53 gene encodes a non-mutated epitope recognized by HLA-B4601-restricted and tumor-reactive CTLs at tumor site."Cancer Res. 15. 854-858 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Fujii T et al.: "Immunohistological Study of Cell Cycle-Related Factors, Oncogene Expression, Cell proliferation in adenocarcinoma of Barrett's Esophagus."Oncol Rep. 10. 427-431 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nakagawa S.Fujii T et al.: "Cell Growth Inhibition by All-trans Retinoic Acid in SKBR-3 Breast Cancer Cells : Involvement of protein kinase Cα and extracellular signal-regulated kinase mitogen-activated protein kinase."Mol Carcinogen. 38. 106-116 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] HIROSHI YANAGA: "Prevention of carcinogenesis of mammary epithelial cells RIII/MG by epigallocatechin gallate"International J of Molecular Medicine. 10. 311-315 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] HIROKO DEGUCHI: "Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell lineT47D"International J of Oncology. 21. 1301-1305 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] TERUHIKO FUJII: "Clinicopathologic study of neovascularization and VEGF expression in superficial esophogeal carcinoma"International J of Oncology. 21. 1181-1187 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] TERUHIKO FUJII: "Immunohistological study of cell cycle-related factors, onco gene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagu"Oncology Reports. 10. 427-431 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi